BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 12077729)

  • 1. Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidemia in diabetes.
    Phillips C; Bennett A; Anderton K; Owens D; Collins P; White D; Tomkin GH
    Metabolism; 2002 Jul; 51(7):847-52. PubMed ID: 12077729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective chylomicron synthesis as a cause of delayed particle clearance in diabetes?
    Phillips C; Madigan C; Owens D; Collins P; Tomkin GH
    Int J Exp Diabetes Res; 2002; 3(3):171-8. PubMed ID: 12458658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsomal triglyceride transfer protein: does insulin resistance play a role in the regulation of chylomicron assembly?
    Phillips C; Owens D; Collins P; Tomkin GH
    Atherosclerosis; 2002 Feb; 160(2):355-60. PubMed ID: 11849658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
    Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
    Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal microsomal triglyceride transfer protein in type 2 diabetic and non-diabetic subjects: the relationship to triglyceride-rich postprandial lipoprotein composition.
    Phillips C; Mullan K; Owens D; Tomkin GH
    Atherosclerosis; 2006 Jul; 187(1):57-64. PubMed ID: 16183064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of dietary cholesterol in the regulation of postprandial apolipoprotein B48 levels in diabetes.
    Taggart C; Gibney J; Owens D; Collins P; Johnson A; Tomkin GH
    Diabet Med; 1997 Dec; 14(12):1051-8. PubMed ID: 9455933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of microsomal triglyceride transfer protein and dietary cholesterol in chylomicron production in diabetes.
    Gleeson A; Anderton K; Owens D; Bennett A; Collins P; Johnson A; White D; Tomkin GH
    Diabetologia; 1999 Aug; 42(8):944-8. PubMed ID: 10491754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between cholesterol absorption and intestinal cholesterol synthesis in the diabetic rat model.
    Gleeson A; Owens D; Collins P; Johnson A; Tomkin GH
    Int J Exp Diabetes Res; 2000; 1(3):203-10. PubMed ID: 11467411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why does the gut choose apolipoprotein B48 but not B100 for chylomicron formation?
    Lo CM; Nordskog BK; Nauli AM; Zheng S; Vonlehmden SB; Yang Q; Lee D; Swift LL; Davidson NO; Tso P
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G344-52. PubMed ID: 18006607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genes that affect cholesterol synthesis, cholesterol absorption, and chylomicron assembly: the relationship between the liver and intestine in control and streptozotosin diabetic rats.
    Lally S; Owens D; Tomkin GH
    Metabolism; 2007 Mar; 56(3):430-8. PubMed ID: 17292734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved metabolic control reduces the number of postprandial apolipoprotein B-48-containing particles in type 2 diabetes.
    Phillips C; Murugasu G; Owens D; Collins P; Johnson A; Tomkin GH
    Atherosclerosis; 2000 Feb; 148(2):283-91. PubMed ID: 10657563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestine-specific MTP and global ACAT2 deficiency lowers acute cholesterol absorption with chylomicrons and HDLs.
    Iqbal J; Boutjdir M; Rudel LL; Hussain MM
    J Lipid Res; 2014 Nov; 55(11):2261-75. PubMed ID: 25030663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and regulation of hamster microsomal triglyceride transfer protein. The regulation is independent from that of other hepatic and intestinal proteins which participate in the transport of fatty acids and triglycerides.
    Lin MC; Arbeeny C; Bergquist K; Kienzle B; Gordon DA; Wetterau JR
    J Biol Chem; 1994 Nov; 269(46):29138-45. PubMed ID: 7961879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
    Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid and apolipoprotein B48 transport in mesenteric lymph and the effect of hyperphagia on the clearance of chylomicron-like emulsions in insulin-deficient rats.
    Martins IJ; Sainsbury AJ; Mamo JC; Redgrave TG
    Diabetologia; 1994 Mar; 37(3):238-46. PubMed ID: 8174836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IRE1beta inhibits chylomicron production by selectively degrading MTP mRNA.
    Iqbal J; Dai K; Seimon T; Jungreis R; Oyadomari M; Kuriakose G; Ron D; Tabas I; Hussain MM
    Cell Metab; 2008 May; 7(5):445-55. PubMed ID: 18460335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary unsaturated fatty acids in type 2 diabetes: higher levels of postprandial lipoprotein on a linoleic acid-rich sunflower oil diet compared with an oleic acid-rich olive oil diet.
    Madigan C; Ryan M; Owens D; Collins P; Tomkin GH
    Diabetes Care; 2000 Oct; 23(10):1472-7. PubMed ID: 11023139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the expression of genes encoding apolipoproteins B100 and B48 and the low density lipoprotein receptor in nonhuman primates. Comparison of dietary fat and cholesterol.
    Sorci-Thomas M; Wilson MD; Johnson FL; Williams DL; Rudel LL
    J Biol Chem; 1989 May; 264(15):9039-45. PubMed ID: 2722816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postprandial apolipoprotein B100 and B48 metabolism in familial combined hyperlipidaemia before and after reduction of fasting plasma triglycerides.
    Castro Cabezas M; Erkelens DW; Kock LA; De Bruin TW
    Eur J Clin Invest; 1994 Oct; 24(10):669-78. PubMed ID: 7851467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, ameliorates lipid metabolism and attenuates atherosclerosis in hyperlipidemic animal models.
    Mera Y; Kawai T; Ogawa N; Odani N; Sasase T; Miyajima K; Ohta T; Kakutani M
    J Pharmacol Sci; 2015 Nov; 129(3):169-76. PubMed ID: 26598005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.